Immunomodulators Flop for COVID-19 Pneumonia Outcomes

(MedPage Today) -- Immunomodulators abatacept (Orencia), cenicriviroc, and infliximab (Remicade) all failed to improve time to recovery for patients hospitalized with COVID-19 pneumonia in the randomized, double-masked ACTIV-1 platform trial....
Source: MedPage Today Infectious Disease - Category: Infectious Diseases Source Type: news